• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨桥蛋白:肝脏疾病的多功能调节剂。

Osteopontin: Versatile modulator of liver diseases.

机构信息

Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.

出版信息

Hepatol Res. 2014 Jan;44(1):22-30. doi: 10.1111/hepr.12166. Epub 2013 Jun 20.

DOI:10.1111/hepr.12166
PMID:23701387
Abstract

Osteopontin (OPN) is a multifunctional protein, involved in pathological conditions including inflammation, immunity, angiogenesis, fibrosis and cancer progression in various tissues. Hepatic inflammation and fibrosis induced by feeding with a diet deficient in methionine and choline (MCD diet) were markedly attenuated in OPN knockout mice when compared with wild-type mice in the model of non-alcoholic steatohepatitis (NASH). Hepatic cholangiocytes, myofibroblastic stellate cells and natural killer T cells were suggested to secret OPN in mice fed an MCD diet. Plasma and hepatic OPN levels were significantly higher in patients with NASH with advanced fibrosis than in those with early fibrosis. Hepatic OPN mRNA level was correlated with hepatic neutrophil infiltration and fibrosis in patients with alcoholic liver diseases. In those with hepatocellular carcinoma (HCC), OPN levels in plasma and HCC were prognostic factors after liver resection or transplantation. Downregulation of OPN inhibited tumor growth and lung metastasis in nude mice implanted with HCC cells. The single nucleotide polymorphism in the promoter region of the OPN gene was shown to be associated with activity of hepatitis in chronic hepatitis C patients, prognosis in patients with HCC, and growth and lung metastasis of HCC xenografts in nude mice. OPN was reported to be a downstream effecter of Hedgehog pathway, which modulates hepatic fibrosis and carcinogenesis. This review focuses on the roles of OPN in hepatic inflammation, fibrosis and cancer progression. Further elucidation of cellular interactions and molecular mechanisms associated with OPN actions may contribute to development of novel strategies for treatment of the liver diseases.

摘要

骨桥蛋白 (OPN) 是一种多功能蛋白,参与多种病理状态,包括炎症、免疫、血管生成、纤维化和癌症进展,涉及多种组织。与野生型小鼠相比,在非酒精性脂肪性肝炎 (NASH) 模型中,缺乏蛋氨酸和胆碱的饮食喂养引起的 OPN 基因敲除小鼠的肝炎症和纤维化明显减轻。在 MCD 饮食喂养的小鼠中,肝胆小管细胞、肌纤维母细胞样星状细胞和自然杀伤 T 细胞被认为分泌 OPN。与早期纤维化患者相比,NASH 伴晚期纤维化患者的血浆和肝 OPN 水平显著升高。酒精性肝病患者的肝 OPN mRNA 水平与肝中性粒细胞浸润和纤维化相关。在肝细胞癌 (HCC) 患者中,血浆和 HCC 中的 OPN 水平是肝切除或移植后患者的预后因素。下调 OPN 抑制了裸鼠植入 HCC 细胞后的肿瘤生长和肺转移。OPN 基因启动子区域的单核苷酸多态性与慢性丙型肝炎患者的肝炎活动、HCC 患者的预后以及裸鼠 HCC 异种移植物的生长和肺转移相关。据报道,OPN 是 Hedgehog 通路的下游效应因子,调节肝纤维化和癌变。本综述重点介绍 OPN 在肝炎症、纤维化和癌症进展中的作用。进一步阐明与 OPN 作用相关的细胞相互作用和分子机制可能有助于开发治疗肝脏疾病的新策略。

相似文献

1
Osteopontin: Versatile modulator of liver diseases.骨桥蛋白:肝脏疾病的多功能调节剂。
Hepatol Res. 2014 Jan;44(1):22-30. doi: 10.1111/hepr.12166. Epub 2013 Jun 20.
2
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.NKT 相关的 hedgehog 和骨桥蛋白驱动非酒精性脂肪性肝病中的纤维化。
Gut. 2012 Sep;61(9):1323-9. doi: 10.1136/gutjnl-2011-301857. Epub 2012 Mar 17.
3
Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.骨桥蛋白受 hedgehog 通路激活诱导,并促进非酒精性脂肪性肝炎纤维化进展。
Hepatology. 2011 Jan;53(1):106-15. doi: 10.1002/hep.23998. Epub 2010 Oct 21.
4
Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.骨桥蛋白是瘦素介导的非酒精性脂肪性肝炎(NASH)纤维化的近端效应因子。
Biochim Biophys Acta. 2016 Jan;1862(1):135-44. doi: 10.1016/j.bbadis.2015.10.028. Epub 2015 Oct 31.
5
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.骨桥蛋白表达上调参与饮食诱导的小鼠非酒精性脂肪性肝炎模型的发展。
Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G264-73. doi: 10.1152/ajpgi.00002.2004. Epub 2004 Mar 25.
6
Role of Osteopontin in Liver Diseases.骨桥蛋白在肝脏疾病中的作用。
Int J Biol Sci. 2016 Aug 6;12(9):1121-8. doi: 10.7150/ijbs.16445. eCollection 2016.
7
Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma.骨桥蛋白对非酒精性肝病及相关肝细胞癌发生发展的影响。
Liver Int. 2020 Jul;40(7):1620-1633. doi: 10.1111/liv.14464. Epub 2020 May 30.
8
The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.转录因子 c-Jun/AP-1 通过调节骨桥蛋白表达促进非酒精性脂肪性肝炎肝纤维化。
Cell Death Differ. 2019 Sep;26(9):1688-1699. doi: 10.1038/s41418-018-0239-8. Epub 2019 Feb 18.
9
[Establishment of a complex alcoholic liver fibrosis mouse model and investigation of OPN and TGF-beta1 hepatic expression].[复合性酒精性肝纤维化小鼠模型的建立及骨桥蛋白和转化生长因子-β1肝脏表达的研究]
Zhonghua Gan Zang Bing Za Zhi. 2013 Mar;21(3):207-12.
10
Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.表没食子儿茶素没食子酸酯减轻了由蛋氨酸和胆碱缺乏饮食诱导的非酒精性脂肪性肝炎。
Eur J Pharmacol. 2015 Aug 15;761:405-12. doi: 10.1016/j.ejphar.2015.05.005. Epub 2015 May 9.

引用本文的文献

1
Intercellular communication between hepatic stellate cells and myofibroblasts mediated by osteopontin and FGF18 promotes liver fibrosis.由骨桥蛋白和FGF18介导的肝星状细胞与肌成纤维细胞之间的细胞间通讯促进肝纤维化。
iScience. 2025 Jun 17;28(7):112932. doi: 10.1016/j.isci.2025.112932. eCollection 2025 Jul 18.
2
Depletion of tumor-reactive HSCs reveals their significance during different stages of liver metastasis.肿瘤反应性肝星状细胞的耗竭揭示了它们在肝转移不同阶段的重要性。
Hepatol Commun. 2025 Mar 24;9(4). doi: 10.1097/HC9.0000000000000669. eCollection 2025 Apr 1.
3
Osteopontin: an indispensable component in common liver, pancreatic, and biliary related disease.
骨桥蛋白:共同的肝、胰和胆相关疾病中不可或缺的组成部分。
J Cancer Res Clin Oncol. 2024 Nov 22;150(12):508. doi: 10.1007/s00432-024-06038-0.
4
Osteokines in Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的成骨细胞因子。
Curr Obes Rep. 2024 Dec;13(4):703-723. doi: 10.1007/s13679-024-00586-9. Epub 2024 Sep 3.
5
Biomarkers of liver diseases.肝脏疾病的生物标志物。
Mol Biol Rep. 2023 Sep;50(9):7815-7823. doi: 10.1007/s11033-023-08666-0. Epub 2023 Jul 24.
6
Therapeutic Cell Repopulation of the Liver: From Fetal Rat Cells to Synthetic Human Tissues.肝脏的治疗性细胞再群体化:从胎鼠细胞到合成的人类组织。
Cells. 2023 Feb 6;12(4):529. doi: 10.3390/cells12040529.
7
Inflammatory-driven NK cell maturation and its impact on pathology.炎症驱动的 NK 细胞成熟及其对病理学的影响。
Front Immunol. 2022 Dec 9;13:1061959. doi: 10.3389/fimmu.2022.1061959. eCollection 2022.
8
A Study on the Serum γ-Glutamyltranspeptidase and Plasma Osteopontin in Alcoholic Liver Disease.酒精性肝病患者血清γ-谷氨酰转肽酶和血浆骨桥蛋白的研究
J Lab Physicians. 2021 Jul 9;14(2):101-108. doi: 10.1055/s-0041-1729479. eCollection 2022 Jun.
9
Clinical and Molecular Implications of Osteopontin in Heart Failure.骨桥蛋白在心力衰竭中的临床及分子学意义
Curr Issues Mol Biol. 2022 Aug 11;44(8):3573-3597. doi: 10.3390/cimb44080245.
10
and Promote Non-alcoholic Steatohepatitis Progression Based on Bioinformatics Analysis and Experimental Studies.基于生物信息学分析和实验研究促进非酒精性脂肪性肝炎进展
Front Med (Lausanne). 2022 Apr 19;9:862278. doi: 10.3389/fmed.2022.862278. eCollection 2022.